BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Krastev ZA. The “return” of hepatitis B. World J Gastroenterol 2006; 12(44): 7081-7086 [PMID: 17131468 DOI: 10.3748/wjg.v12.i44.7081]
URL: https://www.wjgnet.com/1007-9327/full/v12/i44/7081.htm
Number Citing Articles
1
Benedikte Serruys, Freya Van Houtte, Phebe Verbrugghe, Geert Leroux-Roels, Peter Vanlandschoot. Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in miceHepatology 2009; 49(1): 39 doi: 10.1002/hep.22609
2
Min Wu, Yang Xu, Shanshan Lin, Xiaonan Zhang, Li Xiang, Zhenghong Yuan. Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1 Journal of General Virology 2007; 88(12): 3260 doi: 10.1099/vir.0.82959-0
3
Arif Sarowar, Grishma Hirode, Harry L.A. Janssen, Jordan J. Feld. Controversies in Treating Chronic Hepatitis B Virus InfectionClinics in Liver Disease 2021; 25(4): 805 doi: 10.1016/j.cld.2021.06.007
4
R. A. A. Pondé, D. D. P. Cardoso, M. O. Ferro. The underlying mechanisms for the ‘anti-HBc alone’ serological profileArchives of Virology 2010; 155(2): 149 doi: 10.1007/s00705-009-0559-6
5
Haitao Guo, Richeng Mao, Timothy M. Block, Ju-Tao Guo. Production and Function of the Cytoplasmic Deproteinized Relaxed Circular DNA of HepadnavirusesJournal of Virology 2010; 84(1): 387 doi: 10.1128/JVI.01921-09
6
C. Pagnoux, L. Guillevin. The Digestive Involvement in Systemic Autoimmune DiseasesHandbook of Systemic Autoimmune Diseases 2017; 13: 143 doi: 10.1016/B978-0-444-63707-9.00008-8
7
Christian Pagnoux, Loïc Guillevin. Digestive Involvement in Systemic Autoimmune DiseasesHandbook of Systemic Autoimmune Diseases 2008; 8: 191 doi: 10.1016/S1571-5078(07)00015-3
8
R. A. A. Pondé. Molecular mechanisms underlying HBsAg negativity in occult HBV infectionEuropean Journal of Clinical Microbiology & Infectious Diseases 2015; 34(9): 1709 doi: 10.1007/s10096-015-2422-x
9
Yong-Song Guan, Qing He, Ming-Quan Wang, Ping Li. Nuclear factor kappa B and hepatitis virusesExpert Opinion on Therapeutic Targets 2008; 12(3): 265 doi: 10.1517/14728222.12.3.265